Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 654Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3BRISTOL-MYERS SQUIBB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

Brand Name : DAKLINZA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 30MG BASE

Approval Date : 2015-07-24

Application Number : 206843

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

Brand Name : DAKLINZA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 60MG BASE

Approval Date : 2015-07-24

Application Number : 206843

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

Brand Name : DAKLINZA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 90MG BASE

Approval Date : 2016-04-13

Application Number : 206843

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank